Answers are grounded in this paper and cite their sources.
The efficacy and safety of avacopan in Japanese patients with MPA or GPA were comparable to that observed in the overall ADVOCATE study population.
No takes yet. Share an insight, caveat, or question.
Harigai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: